Lupin, Tenpoint Therapeutics Partner to Commercialize Yuvezzi in U.K. and European Markets
MUMBAI; NAPLES, Fla.; WARREN, N.J.; AMSTERDAM; LONDON—Global pharma company Lupin Limited (Bloomberg: LPCIN) has announced that VISUfarma B.V., a wholly owned subsidiary of Lupin, has inked an exclusive…
